Tempest Therapeutics, Inc.
TPST
$0.91
-$0.08-7.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.47M | -43.10M | -26.26M | -36.05M | -43.10M |
| Total Depreciation and Amortization | 251.00K | 258.00K | 266.00K | 250.00K | 281.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.55M | 23.06M | 4.31M | 5.08M | 6.38M |
| Change in Net Operating Assets | -4.06M | -6.60M | -5.13M | -2.67M | -355.00K |
| Cash from Operations | -20.73M | -26.38M | -26.82M | -33.40M | -36.80M |
| Capital Expenditure | -- | -- | -- | -3.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -3.00K | -18.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -4.23M | -6.43M | -8.63M | -10.82M |
| Issuance of Common Stock | 5.78M | 9.45M | 9.23M | 27.07M | 30.80M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.45M | 1.45M | 1.45M | 0.00 | -- |
| Cash from Financing | 7.23M | 6.68M | 4.26M | 18.44M | 19.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.50M | -19.71M | -22.56M | -14.95M | -16.84M |